Search

Your search keyword '"J. Cortes"' showing total 26 results

Search Constraints

Start Over You searched for: Author "J. Cortes" Remove constraint Author: "J. Cortes" Region united states Remove constraint Region: united states
26 results on '"J. Cortes"'

Search Results

1. Physician Opinions on Artificial Intelligence Chatbots In Dermatology: A National Online Cross-Sectional Survey of Dermatologists.

2. Associations Between a Social Determinant of Health Summary Measure and Self-Reported Physical and Mental Health Among Cancer Survivors.

3. Cardiovascular Diseases Increase Cancer Mortality in Adults: NHANES-Continuous Study.

5. "Caminando Con Riesgo": perceptions of occupational injury, workplace safety and workers rights among Spanish-speaking hospitalized patients.

6. Representation of the population in need for pivotal clinical trials in lymphomas.

7. A comparative safety review of targeted therapies for acute myeloid leukemia.

8. Understanding geographic and racial/ethnic disparities in mortality from four major cancers in the state of Georgia: a spatial epidemiologic analysis, 1999-2019.

9. Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology.

10. Oncological care organisation during COVID-19 outbreak.

11. Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States.

12. Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial.

13. Mortality and morbidity in populations in the vicinity of coal mining: a systematic review.

14. Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.

15. In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

16. Cardiovascular and pulmonary adverse events in patients treated with BCR-ABL inhibitors: Data from the FDA Adverse Event Reporting System.

17. Trends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009.

19. Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.

20. The use of bevacizumab among women with metastatic breast cancer: a survey on clinical practice and the ongoing controversy.

21. Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study.

22. Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase.

23. Diagnosis and management of chronic myeloid leukemia: a survey of American and European practice patterns.

24. Emerging safety issues with imatinib and other Abl tyrosine kinase inhibitors.

25. Treatment interruptions and non-adherence with imatinib and associated healthcare costs: a retrospective analysis among managed care patients with chronic myelogenous leukaemia.

26. [Anti-microbial resistance in intensive care units in Bogotá, Colombia, 2001-2003].

Catalog

Books, media, physical & digital resources